Overview
Primary adenocarcinoma of the esophagogastric junction involves malignant transformation in the junction region between the esophagus and stomach. This condition often presents diagnostic and therapeutic challenges due to its location and potential invasiveness 1.Diagnosis
Endoscopic biopsy is essential for definitive diagnosis 1.
Imaging studies such as CT or MRI may help assess tumor extent and regional spread 1.
Tumor staging typically follows the TNM classification system 1.Management
Surgical resection (e.g., esophagectomy or gastrectomy) is often the primary treatment modality 1.
Neoadjuvant therapy (chemoradiation) may be used to downstage tumors before surgery 1.
Adjuvant chemotherapy or chemoradiation may be considered post-surgery based on staging and risk factors 1.
Laser therapy can be employed for palliation in unresectable cases, though bacteremia risk is noted during tumor penetration 1.Special Populations
Antibiotic prophylaxis may be indicated for patients undergoing endoscopic procedures with tumor penetration to prevent bacteremia 1.Key Recommendations
Consider antibiotic prophylaxis for patients undergoing endoscopic procedures that involve penetration through esophagogastric malignancy to prevent bacteremia (Evidence: Moderate) 1.
Neoadjuvant chemoradiation should be evaluated for patients with locally advanced esophagogastric junction adenocarcinoma to improve surgical outcomes (Evidence: Expert opinion) 1.
Surgical resection remains the cornerstone of curative treatment for resectable esophagogastric junction adenocarcinoma (Evidence: Expert opinion) 1.References
1 Wolf D, Fleischer D, Sivak MV. Incidence of bacteremia with elective upper gastrointestinal endoscopic laser therapy. Gastrointestinal endoscopy 1985. link72173-6)